FDA will drop two-study requirement for new drug approvals, aiming to speed access - Associated Press News
AI Summary1 min read
TL;DR
The FDA is eliminating the two-study requirement for new drug approvals to accelerate access, with experts and industry reacting to this regulatory shift.
Tags
FDAdrug approvalsclinical trialsregulatory policypharmaceuticals
- FDA will drop two-study requirement for new drug approvals, aiming to speed access Associated Press News
- ‘Just Agree to It:’ Pazdur Said He Was Told To Cosign FDA’s Reduced Trial Requirements BioSpace
- Experts react to FDA’s shift to single pivotal trials for most drugs Regulatory Affairs Professionals Society | RAPS
- FDA Policy Shift: Impact on AstraZeneca (AZN) and Pharmaceuticals GuruFocus
- FDA to begin requiring on clinical trial TipRanks